<DOC>
	<DOCNO>NCT00274807</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , mitoxantrone , cytarabine , etoposide , work different way stop growth cancer cell , either kill cell stop divide . Giving one drug ( combination chemotherapy ) may kill cancer cell . PURPOSE : This phase II trial study well combination chemotherapy work treat patient newly diagnose acute myeloid leukemia .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Newly Diagnosed Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Determine complete remission rate patient acute myelogenous leukemia treat induction chemotherapy comprise mitoxantrone hydrochloride , cytarabine , etoposide . - Determine feasibility toxicity regimen give patient newly diagnose acute myelogenous leukemia . OUTLINE : Patients receive induction chemotherapy comprise mitoxantrone hydrochloride IV day 1-3 , cytarabine IV continuously 72 hour day 1-3 8-10 , etoposide IV continuously 72 hour day 8-10 . Patients also receive filgrastim ( G-CSF ) subcutaneously daily begin day 4 continue blood count recover . PROJECTED ACCRUAL : A total 40 patient accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute myeloid leukemia Previously untreated disease Previous hydroxyurea and/or corticosteroid acceptable No preexist history hematologic disorder Myelodysplastic feature allow No acute leukemia secondary previous therapy No leukemic meningitis PATIENT CHARACTERISTICS : Bilirubin &lt; 2.0 mg/dL ( unless felt increase hepatic infiltration leukemia ) Creatinine &lt; 2.0 mg/dL Pregnant lactating patient ineligible Fertile patient must use effective contraception No history active congestive heart failure PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 15 ; 17 ) ( q22 ; q12 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
</DOC>